Ellevest, Inc. Rubius Therapeutics, Inc. Transaction History

Ellevest, Inc.

  • $1.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 18, 2022
SELL
$0.79 - $5.98 $18 - $143
-24 Closed
0 $0
Q1 2022

Apr 19, 2022
BUY
$4.25 - $10.4 $102 - $249
24 New
24 $0
Q4 2021

Jan 24, 2022
SELL
$9.68 - $17.74 $183 - $337
-19 Closed
0 $0
Q3 2021

Oct 19, 2021
BUY
$17.6 - $25.91 $334 - $492
19 New
19 $0

Others Institutions Holding RUBY

# of Institutions
2
Shares Held
325
Call Options Held
0
Put Options Held
0
View Full List

About Rubius Therapeutics, Inc.

RUBY Quotes by TradingView
  • Ticker RUBY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,357,000
  • Description
  • Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...
More about RUBY
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email